Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Douglas Bauer, MD

    SchoolUCSF School of Medicine
    Address550 16th Street, 2nd Floor
    San Francisco CA 94158
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California, San FranciscoResidency School of Medicine

      Collapse Overview 
      Collapse Overview
      Dr. Bauer has been a clinician-investigator in the Division of General Internal Medicine at UCSF since 1992, where he maintains a general medicine practice (Mt Zion), teaches students, residents and junior faculty, and is active in clinical research. As an executive member of the San Francisco Coordinating Center, he direct the Endpoints and Medication Coding Groups. He currently serves as the Director of the CTSI-funded K Scholar Program which provides clinical and translational research training, mentoring and funding to promising UCSF faculty from all schools and departments. Prior to the K program he started and directed the CTSI-funded Resident Research Training Program at UCSF. His own research interests include the etiology, diagnosis and treatment of osteoporosis and other skeletal disorders, clinical biomarkers, and thyroid dysfunction. Dr. Bauer is a standing member of the NIH Neurologic, Aging, and Musculoskeletal Epidemiology (NAME) Study Section, a member of the California Technology Assessment Forum, and a Trustee for the National Osteoporosis Foundation.

      Collapse Interests
      Clinical epidemiology, clinical trials (RCTs), osteoporosis, thyroid dysfunction, biomarkers, atypical femoral fractures

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse In The News
      Collapse NIH Awarded Grants
      Collapse Twitter
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Bauer DC. Screening Tests for Osteoporosis: Too Few for Some, Too Many for Others. J Gen Intern Med. 2015 Dec; 30(12):1722-3.
        View in: PubMed
      2. Bauer DC. Clinical practice. Calcium supplements and fracture prevention. N Engl J Med. 2013 Oct 17; 369(16):1537-43.
        View in: PubMed PMC4038300
      3. Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, Myers G, Silverman S, Vesper HW, Lee D, Payette M, Randall S. National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int. 2012 Oct; 23(10):2425-33.
        View in: PubMed PMC4011662
      4. Bauer DC. Atypical femoral fracture risk in patients treated with bisphosphonates. Arch Intern Med. 2012 Jun 25; 172(12):936-7.
        View in: PubMed PMC4014073
      5. Bauer DC. FRAX, falls, and fracture prediction: predicting the future. Arch Intern Med. 2011 Oct 10; 171(18):1661-2.
        View in: PubMed
      6. Bauer DC. Discontinuation of odanacatib and other osteoporosis treatments: here today and gone tomorrow? J Bone Miner Res. 2011 Feb; 26(2):239-41.
        View in: PubMed
      7. Bauer DC, Garnero P, Harrison SL, Cauley JA, Eastell R, Ensrud KE, Orwoll E. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res. 2009 Dec; 24(12):2032-8.
        View in: PubMed PMC2791517
      8. Bauer DC, Rodondi N, Stone KL, Hillier TA. Thyroid hormone use, hyperthyroidism and mortality in older women. Am J Med. 2007 Apr; 120(4):343-9.
        View in: PubMed
      9. Bauer DC, Ewing SK, Cauley JA, Ensrud KE, Cummings SR, Orwoll ES. Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporos Int. 2007 Jun; 18(6):771-7.
        View in: PubMed
      10. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, HeinegÄrd D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006 Aug; 14(8):723-7.
        View in: PubMed
      11. Bauer DC, Garnero P, Bilezikian JP, Greenspan SL, Ensrud KE, Rosen CJ, Palermo L, Black DM. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2006 Apr; 91(4):1370-5.
        View in: PubMed
      12. Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black DM. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res. 2006 Feb; 21(2):292-9.
        View in: PubMed
      13. Bauer DC. Combination and sequential therapy with PTH and bisphosphonates. J Musculoskelet Neuronal Interact. 2004 Dec; 4(4):407.
        View in: PubMed
      14. Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, van der Klift M, Pols HA. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med. 2004 Jan 26; 164(2):146-52.
        View in: PubMed
      15. Bauer DC. HMG CoA reductase inhibitors and the skeleton: a comprehensive review. Osteoporos Int. 2003 Jun; 14(4):273-82.
        View in: PubMed
      16. Bauer DC, Bauer DC, Palermo L, Black D, Cauley JA. Quantitative ultrasound and mortality: a prospective study. Osteoporos Int. 2002 Aug; 13(8):606-12.
        View in: PubMed
      Douglas's Networks
      Related Concepts
      Derived automatically from this person's publications.
      Related Authors
      People who share related concepts with this person.
      Back to TOP